Chen W, Fukuda S, Yoshida S, Kobayashi N, Fukada K, Fan B, Matsumoto S, Kobayashi M, Nakamura Y, Ishikawa Y, Fukushima H, Waseda Y, Tanaka H, Fujii Y. Pioneering AI-guided fluorescence-like navigation in urological surgery: real-time ureter segmentation during robot-assisted radical cystectomy using convolutional neural network. J Robot Surg, 19(1): 188, 2025. PubMed
Yamamoto T, Yoshida S, Maezawa Y, Tamiya T, Toide M, Fukushima H, Uehara S, Araki S, Ito M, Kobayashi S, Yoshinaga A, Kawamura N, Takazawa R, Sakai Y, Ootsuka Y, Tsukamoto T, Nagahama K, Tanaka H, Kitabayashi R, Hanazawa R, Ishikuro M, Sato H, Koike R, Fujii Y. Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (ADVISR) protocol. BMJ Open, 15(3): e094230, 2025. PubMed
Matsumoto S, Ishikawa Y, Fukushima H, Yamamoto K, Tsujimoto K, Kimura K, Waseda Y, Tanaka H, Yoshida S, Fujii Y.A case of bladder paraganglioma completely resected by transurethral endoscopic en-bloc resection of bladder tumor. IJU Case Rep, 8(2): 93–96, 2025. PubMed
Okuyama S, Fujimura D, Furusawa A, Fukushima H, Okada R, Ogura T, Nishimura M, Choyke PL, Kobayashi H. Urinary IR700 ligand as an early biomarker of therapeutic efficacy of near-infrared photoimmunotherapy. ACS Omega, 10(7): 6983–6991, 2025. PubMed
Horie T, Fujiwara M, Waseda Y, Tanaka H, Yoshida S, Fujii Y. Radiomics analysis using non-contrast computed tomography for predicting high-dependency unit admission in patients with acute pyelonephritis. Int J Urol, 32(1): 121–123, 2025.PubMed
Sato K, Takemura K, Oki R, Urasaki T, Yoneoka Y, Fujiwara R, Yasuda Y, Oguchi T, Numao N, Yamamoto S, Yonese J, Kume H, Yuasa T. Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies. Urol Oncol, 2025. PubMed
Takao S, Fukushima H, Furusawa A, Kato T, Okuyama S, Kano M, Yamamoto H, Suzuki M, Kano M, Choyke PL, Kobayashi H. Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. Cancer Immunol Immunother, 74(2): 48, 2025. PubMed
Yamamoto H, Furusawa A, Fukushima H, Takao S, Suzuki M, Kano M, Kano M, Okuyama S, Kitamura K, Choyke PL, Kobayashi H. Impact of Vitamin C on Immune Response and Edema Following Near-Infrared Photoimmunotherapy (NIR-PIT). Cancer Sci. 2025 Jul;116(7):1836-1846. PubMed
Fukushima H, Takao S, Furusawa A, Suzuki M, Yang Y, Ricketts CJ, Kano M, Okuyama S, Yamamoto H, Kano M, Ball MW, Choyke PL, Linehan WM, Kobayashi H. Carbonic anhydrase-9-targeted near-infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma. Int J Cancer. 2025 Jun 15;156(12):2377-2388. PubMed
